BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3036032)

  • 1. Lactate dehydrogenase values and bone scans as predictors of bone marrow involvement in small-cell lung cancer.
    Hamrick RM; Murgo AJ
    Arch Intern Med; 1987 Jun; 147(6):1070-1. PubMed ID: 3036032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of the bone scan and bone marrow biopsy staging small cell lung cancer.
    Levitan N; Byrne RE; Bromer RH; Faling LJ; Caslowitz P; Pattern DH; Hong WK
    Cancer; 1985 Aug; 56(3):652-4. PubMed ID: 2988751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological, biochemical and bone scan findings in patients with marrow carcinoma.
    Campbell LJ; Van der Weyden MB
    Pathology; 1991 Jul; 23(3):198-201. PubMed ID: 1664079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).
    Byhardt RW; Hartz A; Libnoch JA; Hansen R; Cox JD
    Int J Radiat Oncol Biol Phys; 1986 May; 12(5):771-7. PubMed ID: 3011712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
    Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
    J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallium scans for staging small cell lung cancer.
    Brereton HD; Line BR; Londer HN; O'Donnell JF; Kent CH; Johnson RE
    JAMA; 1978 Aug; 240(7):666-7. PubMed ID: 209225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lactate dehydrogenase and bone marrow metastases in small-cell carcinoma of the lung.
    N Engl J Med; 1985 Sep; 313(12):759-60. PubMed ID: 2993885
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum lactate dehydrogenase and bone marrow involvement in small-cell carcinoma of the lung.
    Doll DC
    N Engl J Med; 1985 May; 312(19):1262. PubMed ID: 2985990
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostic factors in unresectable lung cancer].
    Urata A
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma.
    Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    J Cancer Res Clin Oncol; 1998; 124(3-4):215-9. PubMed ID: 9619749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal CT in the staging of small cell carcinoma of the lung.
    Whitley NO; Mirvis SE
    Crit Rev Diagn Imaging; 1989; 29(2):103-16. PubMed ID: 2540935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneoscopy in the staging of 190 patients with small-cell anaplastic carcinoma of the lung with special reference to subtyping.
    Dombernowsky P; Hirsch F; Hansen HH; Hainau B
    Cancer; 1978 May; 41(5):2008-12. PubMed ID: 206345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lactate dehydrogenase in small-cell lung cancer.
    Van den Brande P; Demedts M
    N Engl J Med; 1989 Jan; 320(1):61. PubMed ID: 2535892
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody.
    Stahel RA; Mabry M; Skarin AT; Speak J; Bernal SD
    J Clin Oncol; 1985 Apr; 3(4):455-61. PubMed ID: 2984342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers.
    Gronowitz JS; Steinholtz L; Källander CF; Hagberg H; Bergh J
    Cancer; 1986 Jul; 58(1):111-8. PubMed ID: 3011236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variables predictive of bone marrow metastasis.
    Chernow B; Wallner SF
    Cancer; 1978 Nov; 42(5):2373-8. PubMed ID: 719614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging and clinical prognostic factors for small-cell lung cancer.
    Argiris A; Murren JR
    Cancer J; 2001; 7(5):437-47. PubMed ID: 11693903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis.
    Hermes A; Gatzemeier U; Waschki B; Reck M
    Respir Med; 2010 Dec; 104(12):1937-42. PubMed ID: 20719490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment serum LDH as additional staging parameter in small-cell lung carcinoma.
    Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    Neth J Med; 1998 Feb; 52(2):65-70. PubMed ID: 9557528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone evaluation in microcellular cancer treated by chemotherapy].
    Seigneur J; Albrecht N; Feintrenie X; Chambre JF; Lamy P
    Rev Pneumol Clin; 1985; 41(6):365-74. PubMed ID: 3010429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.